Kanwar Indulata, Sah Abhishek K, Suresh Preeti K
University Institute of Pharmacy, Faculty of Technology, Pt. Ravishankar Shukla University, Raipur (CG), India.
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur-492010, Chhattisgarh, India.
Curr Pharm Des. 2017;23(14):2084-2095. doi: 10.2174/1381612822666161124154549.
Oral diseases like dental caries and periodontal disease are directly associated with the capability of bacteria to form biofilm. Periodontal diseases have been associated to anaerobic Gram-negative bacteria forming a subgingival plaque (Porphyromonas gingivalis, Actinobacillus, Prevotella and Fusobacterium). Biofilm is a complex bacterial community that is highly resistant to antibiotics and human immunity. Biofilm communities are the causative agents of biological developments such as dental caries, periodontitis, peri-implantitis and causing periodontal tissue breakdown. The review recapitulates the latest advancements in treatment of clinical biofilm infections and scientific investigations, while these novel anti-biofilm strategies are still in nascent phases of development, efforts dedicated to these technologies could ultimately lead to anti-biofilm therapies that are superior to the current antibiotic treatment. This paper provides a review of the literature focusing on the studies on biofilm in the oral cavity, formation of dental plaque biofilm, drug resistance of bacterial biofilm and the antibiofilm approaches as biofilm preventive agents in dentistry, and their mechanism of biofilm inhibition.
龋齿和牙周病等口腔疾病与细菌形成生物膜的能力直接相关。牙周病与形成龈下菌斑的厌氧革兰氏阴性菌(牙龈卟啉单胞菌、放线杆菌、普氏菌和梭杆菌)有关。生物膜是一个复杂的细菌群落,对抗生素和人体免疫力具有高度抗性。生物膜群落是诸如龋齿、牙周炎、种植体周围炎等生物学进展的致病因素,并会导致牙周组织破坏。本综述概述了临床生物膜感染治疗和科学研究的最新进展,虽然这些新型抗生物膜策略仍处于发展初期,但致力于这些技术的努力最终可能会带来优于当前抗生素治疗的抗生物膜疗法。本文对文献进行了综述,重点关注口腔生物膜的研究、牙菌斑生物膜的形成、细菌生物膜的耐药性以及作为牙科生物膜预防剂的抗生物膜方法及其生物膜抑制机制。